CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.25
-2.79 (-5.58%)
Nov 10, 2026, 10:41 AM EST - Market open
CRISPR Therapeutics AG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
| 12.67 | 10.18 | 1.46 | 0.86 | 0.89 | 0.89 | 0.87 | 35.69 | 0.6 | 0.52 | 0.5 | 201.21 | - | 70 | 100 | 0.01 | 0.09 | 0.16 | 0.94 | 12.9 | |
Revenue Growth (YoY) | 1325.08% | 1041.37% | 68.55% | -97.58% | 47.67% | 72.53% | 71.63% | -82.26% | - | -99.26% | -99.50% | 3353333.33% | - | 44203.80% | 10538.30% | -99.95% | -88.59% | -99.98% | 74.40% | 3386.22% |
Cost of Revenue | 113.17 | 107.42 | 114.52 | 137.23 | 116.02 | 115.05 | 129.99 | 82.16 | 93.31 | 132.3 | 123.14 | 115.14 | 114.12 | 146.19 | 142.13 | 110.38 | 155.48 | 157.15 | 148.89 | 134.92 |
Gross Profit | -100.5 | -97.24 | -113.07 | -136.37 | -115.13 | -114.16 | -129.13 | -46.46 | -92.71 | -131.78 | -122.63 | 86.06 | -114.12 | -76.19 | -42.13 | -110.37 | -155.39 | -156.99 | -147.95 | -122.02 |
Selling, General & Admin | 17.87 | 17.55 | 17.18 | 18.4 | 16.93 | 18.92 | 19.3 | 18.12 | 17.42 | 19.48 | 17.95 | 16.48 | 18.29 | 19.03 | 22.36 | 21.17 | 27 | 26.27 | 28.02 | 23.68 |
Operating Expenses | 17.87 | 17.55 | 17.18 | 18.4 | 16.93 | 18.92 | 19.3 | 18.12 | 17.42 | 19.48 | 17.95 | 16.48 | 18.29 | 19.03 | 22.36 | 21.17 | 27 | 26.27 | 28.02 | 23.68 |
Operating Income | -118.37 | -114.8 | -130.25 | -154.76 | -132.06 | -133.07 | -148.42 | -64.59 | -110.13 | -151.26 | -140.59 | 69.58 | -132.41 | -95.22 | -64.49 | -131.54 | -182.39 | -183.26 | -175.97 | -145.7 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.81 |
Interest & Investment Income | - | - | - | - | - | - | - | - | - | - | - | 20 | 20.67 | 18.41 | 12.74 | 11.49 | 7.26 | 3.54 | 0.36 | - |
Other Non Operating Income (Expenses) | 18.68 | 27.08 | 8.16 | 24.77 | 26.24 | 22.07 | 13.54 | 27.98 | 25.06 | 26.14 | 24.72 | - | - | - | - | - | - | - | - | 6 |
EBT Excluding Unusual Items | -99.69 | -87.72 | -122.09 | -130 | -105.82 | -111 | -134.89 | -36.61 | -85.07 | -125.12 | -115.87 | 89.58 | -111.74 | -76.82 | -51.75 | -120.05 | -175.12 | -179.72 | -175.61 | -143.5 |
Pretax Income | -111.36 | -90.19 | -122.09 | -130 | -105.82 | -207.26 | -134.89 | -36.61 | -85.07 | -125.12 | -115.87 | 89.58 | -111.74 | -76.82 | -51.75 | -120.05 | -175.12 | -179.72 | -175.61 | -143.5 |
Income Tax Expense | 0.07 | 0.96 | 0.84 | 0.61 | 0.62 | 1.29 | 1.11 | 0.7 | 0.88 | 1.29 | 0.72 | 0.23 | 0.41 | 0.92 | 1.32 | -9.48 | -0.58 | 6.12 | 3.61 | -2.25 |
Earnings From Continuing Operations | -111.44 | -91.15 | -122.93 | -130.61 | -106.44 | -208.55 | -136 | -37.31 | -85.94 | -126.41 | -116.59 | 89.35 | -112.15 | -77.74 | -53.07 | -110.58 | -174.55 | -185.83 | -179.22 | -141.25 |
Net Income | -111.44 | -91.15 | -122.93 | -130.61 | -106.44 | -208.55 | -136 | -37.31 | -85.94 | -126.41 | -116.59 | 89.35 | -112.15 | -77.74 | -53.07 | -110.58 | -174.55 | -185.83 | -179.22 | -141.25 |
Net Income to Common | -111.44 | -91.15 | -122.93 | -130.61 | -106.44 | -208.55 | -136 | -37.31 | -85.94 | -126.41 | -116.59 | 89.35 | -112.15 | -77.74 | -53.07 | -110.58 | -174.55 | -185.83 | -179.22 | -141.25 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 97 | 97 | 96 | 95 | 91 | 87 | 86 | 85 | 85 | 85 | 82 | 80 | 79 | 79 | 79 | 78 | 78 | 78 | 77 | 77 |
Shares Outstanding (Diluted) | 97 | 97 | 96 | 95 | 91 | 87 | 86 | 85 | 85 | 85 | 82 | 81 | 79 | 79 | 79 | 78 | 78 | 78 | 77 | 77 |
Shares Change (YoY) | 5.95% | 10.85% | 11.77% | 11.47% | 7.12% | 2.53% | 5.07% | 5.09% | 7.33% | 7.37% | 3.96% | 3.82% | 1.79% | 2.04% | 2.05% | 2.20% | 2.27% | -3.65% | 2.79% | 7.53% |
EPS (Basic) | -1.15 | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.12 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.40 | -2.32 | -1.84 |
EPS (Diluted) | -1.15 | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.09 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.40 | -2.32 | -1.84 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -90.1 | -84.15 | -109.4 | -93.07 | -84.71 | -114 | -54.15 | -50.29 | -107.13 | -96.29 | 109.03 | -96.81 | -41.97 | -136.8 | 5.74 | -119.52 | -111.24 | -151.59 | -150.59 | -95.22 |
Free Cash Flow Per Share | -0.93 | -0.87 | -1.14 | -0.98 | -0.93 | -1.31 | -0.63 | -0.59 | -1.26 | -1.13 | 1.33 | -1.19 | -0.53 | -1.73 | 0.07 | -1.53 | -1.43 | -1.96 | -1.95 | -1.24 |
Gross Margin | - | - | - | - | - | - | - | -130.18% | - | - | - | 42.77% | - | -108.84% | -42.13% | - | - | - | - | - |
Operating Margin | -934.33% | -1127.55% | -8933.33% | -17912.50% | -14854.78% | -14918.27% | -17158.84% | -180.96% | -18294.02% | -29257.25% | -27894.25% | 34.58% | - | -136.03% | -64.49% | -2192350.00% | -194029.79% | -115987.34% | -18720.43% | -1129.53% |
Profit Margin | -879.60% | -895.33% | -8431.48% | -15117.24% | -11973.12% | -23379.93% | -15722.08% | -104.54% | -14276.08% | -24450.29% | -23133.13% | 44.41% | - | -111.06% | -53.06% | -1842916.67% | -185690.43% | -117616.46% | -19065.64% | -1095.03% |
Free Cash Flow Margin | -711.17% | -826.50% | -7503.50% | -10771.99% | -9528.46% | -12779.93% | -6260.46% | -140.89% | -17796.01% | -18624.57% | 21633.13% | -48.12% | - | -195.43% | 5.74% | -1991983.33% | -118335.11% | -95940.51% | -16020.11% | -738.20% |
EBITDA | -114.13 | -110.52 | -125.93 | -149.1 | -127.63 | -128.42 | -143.69 | -59.75 | -105.39 | -146.42 | -135.75 | 74.48 | -127.49 | -90.26 | -59.44 | -125.7 | -177.37 | -175.99 | -169.93 | -139.44 |
EBITDA Margin | - | - | - | - | - | - | - | -167.40% | - | - | - | 37.02% | - | -128.95% | -59.44% | - | - | - | - | - |
D&A For EBITDA | 4.24 | 4.28 | 4.32 | 5.66 | 4.43 | 4.65 | 4.74 | 4.84 | 4.74 | 4.85 | 4.83 | 4.9 | 4.93 | 4.96 | 5.05 | 5.85 | 5.02 | 7.27 | 6.04 | 6.26 |
EBIT | -118.37 | -114.8 | -130.25 | -154.76 | -132.06 | -133.07 | -148.42 | -64.59 | -110.13 | -151.26 | -140.59 | 69.58 | -132.41 | -95.22 | -64.49 | -131.54 | -182.39 | -183.26 | -175.97 | -145.7 |
EBIT Margin | - | - | - | - | - | - | - | -180.96% | - | - | - | 34.58% | - | -136.03% | -64.49% | - | - | - | - | - |
Effective Tax Rate | - | - | - | - | - | - | - | - | - | - | - | 0.26% | - | - | - | - | - | - | - | - |
Revenue as Reported | 12.67 | 10.18 | 1.46 | 0.86 | 0.89 | 0.89 | 0.87 | 35.69 | 0.6 | 0.52 | 0.5 | 201.21 | - | 70 | 100 | 0.01 | 0.09 | 0.16 | 0.94 | 12.9 |